E3 PreliminaryPreliminaryPEM unclearObservationalPeer-reviewedMachine draft
Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
Fark, A R · The Journal of family practice · 1991
Quick Summary
This study looked at whether Epstein-Barr virus (EBV), the virus that causes infectious mononucleosis (mono), might be the cause of ME/CFS. Researchers found that some people with chronic fatigue had high levels of antibodies (immune markers) against EBV, and some of them had never fully recovered from a previous mono infection. The study suggests a possible link between EBV infection and the development of chronic fatigue, though it doesn't prove the virus directly causes ME/CFS.
Why It Matters
This research addresses a longstanding hypothesis that EBV may play an etiologic role in ME/CFS, particularly in post-infectious presentations. For patients whose ME/CFS began after mono, this study provides early evidence suggesting their concern about a viral trigger may have biological basis, and highlights the need for better understanding of how acute EBV infection can lead to chronic illness.
Observed Findings
- 83% of 23 chronic fatigue patients had persistently elevated antibodies to EBV early antigen in modest titers
- Ten patients with chronic fatigue had never fully recovered from a prior episode of acute infectious mononucleosis
- Multiple EBV antigen complexes (early antigen, viral capsid antigen, Epstein-Barr nuclear antigen) are detectable in EBV-infected cells via immunofluorescence
- Other studies reported similar associations between persistently elevated EBV-specific antibodies and chronic symptoms in post-mononucleosis patients
Inferred Conclusions
- EBV may play a role in the pathogenesis of ME/CFS, particularly in patients whose illness began after acute mononucleosis
- Persistently elevated EBV antibodies may represent an abnormal or incomplete immune response following primary infection
- The different EBV antigen complexes may be markers of different stages of viral replication or immune dysfunction
Remaining Questions
- Does elevated EBV antibody indicate active viral replication, persistent latent infection, or abnormal immune memory?
- What proportion of EBV-infected individuals develop chronic fatigue, and what factors determine this outcome?
- Are elevated EBV antibodies present at symptom onset or only detected later during chronic illness?
What This Study Does Not Prove
This study does not prove that EBV causes ME/CFS, only that some patients with chronic fatigue have elevated EBV antibodies—which could reflect past infection, viral reactivation, or immune dysfunction rather than active causation. The retrospective nature of symptom reporting and absence of matched controls means alternative explanations cannot be ruled out. Elevated antibodies alone do not establish that the virus is responsible for ongoing symptoms.
Tags
Symptom:Fatigue
Biomarker:Autoantibodies
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleExploratory Only
Metadata
- PMID
- 1846641
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →